Expression of hMLH1 and hMSH2 proteins in ameloblastomas and tooth germs.

Med Oral Patol Oral Cir Bucal

School of Dentistry, Molecular Pathology Area, Universidad de la República, Las Heras 1925, Montevideo, Uruguay,

Published: March 2018

Background: Mismatch repair proteins (MMRPs) are a group of nuclear enzymes that participate in the repair of base mismatches that occur during DNA replication in all proliferating cells. The most studied MMRPs are hMSH2 and hMLH1, which are known to be highly expressed in normal tissues. A loss of MMRPs leads to the accumulation of DNA replication errors in proliferating cells. Ki-67 is a biomarker regarded to be the gold-standard tool for determining cell proliferation by immunohistochemical methods. The aim of this study was to investigate the immunohistochemical expression of hMLH1, hMSH2 and Ki-67 proteins in ameloblastomas and tooth germs, to contribute to the understanding of the development of this odontogenic neoplasm.

Material And Methods: Immunohistochemical assays to determine the presence of proteins hMSH2, hMLH1 and Ki-67 were performed in 80 ameloblastomas (40 solid and 40 unicystic) and five tooth germs.

Results: Unicystic ameloblastomas showed higher MMRP expression (hMLH1: 62.5 ± 43.4; hMSH2: 83.3 ± 47.8) than did solid ameloblastomas (hMLH1: 59.4 ± 13.5; hMSH2: 75.8 ± 40.2). Additionally, the cell proliferation index assessed by Ki-67 was inversely proportional to the expression of MMRP. Comparison between tooth germs and ameloblastoma revealed significantly higher expression of hMLH1, hMSH2 and Ki-67 in tooth germs (p=0.02).

Conclusions: The differences of MMRP and Ki-67 immunoexpression between ameloblastomas and tooth germ suggest that alterations in the MMRP mechanisms could participate in the biological behavior of ameloblastomas.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911352PMC
http://dx.doi.org/10.4317/medoral.22210DOI Listing

Publication Analysis

Top Keywords

expression hmlh1
16
tooth germs
16
hmlh1 hmsh2
12
ameloblastomas tooth
12
proteins ameloblastomas
8
dna replication
8
proliferating cells
8
hmsh2 hmlh1
8
cell proliferation
8
hmsh2 ki-67
8

Similar Publications

Article Synopsis
  • - Ochratoxin A (OTA) is a harmful mycotoxin classified as a possible human carcinogen that can lead to DNA damage, genomic instability, and cell cycle disruptions.
  • - A study on immortalized human gastric epithelial cells (GES-1) revealed that OTA exposure triggers G phase arrest and enhances the expression of DNA repair protein hMLH1, along with phosphorylation of p53 and p21.
  • - Inhibiting hMLH1 with siRNA prevented the activation of the p53-p21 signaling pathway and reversed the G phase arrest caused by OTA, highlighting the critical role of the hMLH1-p53-p21 pathway in this process.
View Article and Find Full Text PDF

Duodenal type follicular lymphoma (DFL), a rare entity of follicular lymphoma (FL), is clinically indolent and is characterized by a low histological grade compared with nodal follicular lymphoma (NFL). Our previous reports revealed that DFL shares characteristics of both NFL and mucosa-associated lymphoid tissue (MALT) lymphoma in terms of clinical and biological aspects, suggesting its pathogenesis may involve antigenic stimulation. In contrast to NFL, the genomic methylation status of DFL is still challenging.

View Article and Find Full Text PDF

Background: The DNA mismatch repair (MMR) system serves as a sophisticated guardian of the precise functioning of the human genome. Dysregulation within this system is linked to the oncogenesis process. Reduced expression of MMR system proteins identified in salivary gland tumors (SGTs) suggests an increased risk of tumoral occurrence.

View Article and Find Full Text PDF

To investigate the effects of 3'UTR genotype on promotor methylation of tumor-related genes in 22 patients with sporadic colorectal cancer (CRC) from southern Iran. We evaluated the correlations of 3'UTR genotype with promoter methylation of and genes in CRC patients. The polymorphism of 3'UTR was evaluated through mutagenically specific PCR.

View Article and Find Full Text PDF

Aims: The Lynch syndrome (LS) screening algorithm requires BRAF testing as a fundamental step to distinguish sporadic from LS-associated colorectal carcinomas (CRC). BRAF testing by immunohistochemistry (IHC) has shown variable results in the literature. Our aim was to analyse concordance between BRAF IHC and BRAF molecular analysis in a large, mono-institutional CRC whole-slide, case series with laboratory validation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!